Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

Share Price is delayed by 15 minutes
Get Live Data
62.75    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.50 (4.065%)
Market Cap: £5.76m
CPP Live PriceLast checked at - London Stock Exchange

Intraday Cppgroup Share Chart

Form 8.3 - CPP GROUP plc

10 May 2013 16:51

RNS Number : 4871E
Jonathan Walker
10 May 2013
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Jonathan Walker

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

CPP GROUP plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

10/05/13

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,500,000

2.0

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

3,500,000

2.0

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary Shares

Purchase

250,000

5p

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

10/05/13

Contact name:

Jonathan Walker

Telephone number:

07771844367

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETEASSEFLEDEFF
Date   Source Headline
5th Jun 20264:18 pmRNSPosting of Annual Report and Notice of AGM
5th Jun 20264:10 pmRNSHolding(s) in Company
2nd Jun 20267:00 amRNSPRELIMINARY RESULTS YEAR ENDED 31 DECEMBER 2025
22nd Apr 20267:00 amRNSBLOCK LISTING 6 MONTHLY RETURN AND CANCELLATION
10th Apr 202612:34 pmRNSCompany Update
16th Mar 20267:00 amRNSCompany Update
16th Mar 20267:00 amRNSCompany Update
20th Jan 20267:00 amRNSBoard Appointment and Review of AIM Listing Status
7th Jan 20267:00 amRNSBlock listing Interim Review
9th Dec 20251:41 pmRNSHolding(s) in Company
5th Dec 20253:07 pmRNSTotal Voting Rights
21st Oct 20253:45 pmRNSBlock listing Interim Review
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20253:09 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSHALF YEAR REPORT FOR SIX MONTHS ENDED 30 JUNE 2025
25th Sep 20257:12 amRNSCentral functions reorganisation & cost reductions
17th Sep 20259:13 amRNSCompletion of Disposal of CPP India
15th Sep 20257:00 amRNSUpdate regarding the Disposal of CPP India
2nd Sep 202510:34 amRNSChange of Registered Office
14th Aug 20251:28 pmRNSResult of General Meeting
29th Jul 20251:25 pmRNSPublication of Circular Notice of General Meeting
23rd Jul 20257:00 amRNSTransformation of CPP Group: Disposal of CPP India
4th Jul 20257:00 amRNSBlock listing Interim Review
24th Jun 20257:00 amRNSHolding(s) in Company
20th Jun 20257:00 amRNSHolding(s) in Company
18th Jun 20257:00 amRNSTransformation of CPP Group
30th May 20257:00 amRNSHolding(s) in Company
8th May 20257:00 amRNSResult of AGM
24th Apr 20257:00 amRNSBlock listing Interim Review
1st Apr 202511:21 amRNSPosting of Annual Report and Notice of AGM
25th Mar 20257:00 amRNSFULL YEAR RESULTS FOR YEAR ENDED 31 DECEMBER 2024
17th Jan 20257:00 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Update for Financial Year 2024
6th Jan 20257:00 amRNSBlock listing Interim Review
18th Nov 20247:00 amRNSDirectorate Change
22nd Oct 20247:00 amRNSBlock listing Interim Review
19th Sep 20247:00 amRNSHolding(s) in Company
17th Sep 20247:00 amRNSHalf-year Report for six months ended 30 June 2024
10th Sep 20247:00 amRNSAccelerated disposal of Globiva
6th Aug 20247:00 amRNSHolding(s) in Company
2nd Aug 20247:00 amRNSTotal Voting Rights
18th Jul 20247:00 amRNSTrading update for six months ended 30 June 2024
5th Jul 20247:00 amRNSBlock listing Interim Review
4th Jul 20247:00 amRNSDirector/PDMR Shareholding
2nd Jul 20247:00 amRNSHolding(s) in Company
2nd Jul 20247:00 amRNSExercise of Options and Director Shareholdings
1st Jul 20247:00 amRNSNominated Adviser and Broker
28th Jun 20247:00 amRNSDirector Shareholdings
14th Jun 20247:00 amRNSDisposal of Italian Legacy Business
8th May 20247:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.